PROCAINAMIDE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C13H21N3O
Molecular Weight	235.3253
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PROCAINAMIDE

Structure Search

SMILES

CCN(CC)CCNC(=O)C1=CC=C(N)C=C1

InChI

InChIKey=REQCZEXYDRLIBE-UHFFFAOYSA-N

InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)

HIDE SMILES / InChI

Molecular Formula	C13H21N3O
Molecular Weight	235.3253
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:16:04 UTC 2023` Edited by `admin` on `Fri Dec 15 16:16:04 UTC 2023`
Record UNII	L39WTC366D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PROCAINAMIDE

Official Name

English

PROCAINAMIDE [HSDB]

Common Name

English

NOVOCAINAMIDE

Common Name

English

Procainamide [WHO-DD]

Common Name

English

4-AMINO-N-(2-DIETHYLAMINOETHYL) BENZAMIDE

Common Name

English

NSC-27461

Code

English

SP 100 (PHARMACEUTICAL)

Common Name

English

PROCAINAMIDE [VANDF]

Common Name

English

procainamide [INN]

Common Name

English

N-(2-(DIETHYLAMINO)ETHYL)-4-AMINOBENZAMIDE

Systematic Name

English

BENZAMIDE, 4-AMINO-N-(2-(DIETHYLAMINO)ETHYL)-

Systematic Name

English

Classification Tree Code System Code

NDF-RT

N0000175426

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

LIVERTOX

NBK548477

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

NCI_THESAURUS

C93038

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

WHO-VATC

QC01BA02

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

WHO-ATC

C01BA02

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

NCI_THESAURUS

C47793

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

Code System Code Type Description

MESH

D011342

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

HSDB

3170

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

IUPHAR

4811

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

NSC

27461

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

SMS_ID

100000081092

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

CAS

51-06-9

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

ECHA (EC/EINECS)

200-078-8

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

LACTMED

Procainamide

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

ChEMBL

CHEMBL640

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

DRUG BANK

DB01035

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

FDA UNII

L39WTC366D

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

CHEBI

8428

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

PUBCHEM

4913

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

EPA CompTox

DTXSID7023512

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

NCI_THESAURUS

C61905

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

RXCUI

8700

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

RxNorm

DRUG CENTRAL

2270

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

WIKIPEDIA

PROCAINAMIDE

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

DAILYMED

L39WTC366D

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

INN

4179

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

EVMPD

SUB10055MIG

Created by admin on Fri Dec 15 16:16:05 UTC 2023 , Edited by admin on Fri Dec 15 16:16:05 UTC 2023

PRIMARY

Related Record Type Details


					B46KUN2O9L

MATE-2

TRANSPORTER -> INHIBITOR


					ONY583280Z

OCT-1

TRANSPORTER -> INHIBITOR


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> INHIBITOR


					4007E25Z4Z

OCT-3

TRANSPORTER -> INHIBITOR


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> SUBSTRATE

Qualification:

Vmax

Amount:


					B46KUN2O9L

MATE-2

TRANSPORTER -> SUBSTRATE

Qualification:

Km

Amount:


					B46KUN2O9L

MATE-2

TRANSPORTER -> SUBSTRATE

Qualification:

Vmax

Amount:


					515ZW3T4Z5

OCTN-1

TRANSPORTER -> INHIBITOR


					L5R0QCN8LZ

DNA (CYTOSINE-5)-METHYLTRANSFERASE 1

TARGET -> INHIBITOR

Comments:

Inhibits DNMT1 on a hemimethylated substrate

Qualification:

Ki

Amount:


					SI4064O0LX

PROCAINAMIDE HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> SUBSTRATE

Qualification:

Km

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Amount:

Related Record Type Details


					910Q707V6F

METABOLITE -> PARENT

Comments:

Metabolite to parent drug ratio in non-uraemic human plasma.

Interaction Type:

METABOLITE TO PARENT DRUG RATIO

Qualification:

PLASMA; URINE

Amount:


					910Q707V6F

METABOLITE -> PARENT

Comments:

Percent of dose excreted in urine as metabolite.

Interaction Type:

AMOUNT EXCRETED

Qualification:

URINE

Amount:


					910Q707V6F

METABOLITE ACTIVE -> PARENT

Amount:

Related Record Type Details


					L39WTC366D

ACTIVE MOIETY

Amount: